À propos de ce podcast
Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. <br/><br/><a href="https://himshouse.substack.com?utm_medium=podcast">himshouse.substack.com</a>
79 épisodes · Investeren
Hims House
À propos de ce podcast
Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. <br/><br/><a href="https://himshouse.substack.com?utm_medium=podcast">himshouse.substack.com</a>
Épisodes récents
- Finnrick CEO on gray market peptides, fake bodega vials, and China's manufacturing prowess1 oct. · 40 min
- OpenLoop CEO: the peptide gray market is 2-3x bigger than analyst estimates, likely $6-8 billion16 sept. · 30 min
- HIMS stock token hit $132 on Robinhood over the weekend due to ... $BONER coin?! 😳3 sept. · 39 min
- 🚨 THE FTC SUES HIMS & HERS -- Full breakdown with Gaston Kroub2 sept. · 54 min
- Bijan Salehizadeh - Eli Lilly's War on Compounded GLP-1s, Peptides, Retatrutide, and Hims vs Ro26 août · 1 h 00 min
- Enhanced Group CEO: Hot peptide summer is coming — but likely not till 20277 août · 54 min
- 🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem27 juil. · 1 h 00 min
- The FDA peptides vote is days away. This insider expects approval15 juil. · 1 h 01 min
- Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share7 juil. · 1 h 01 min
- 🚨 EXCLUSIVE: Hims board member David Wells on why he bought $1.2M of Hims1 juil. · 51 min
podlinkr.com/fr/hims-house
Pour une affiche ou une diapo.